The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells

Shuiqing Hu, Qingqiong Luo, Biyun Cun, Dan Hu, Shengfang Ge, Xianqun Fan, Fuxiang Chen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Uveal melanomas are highly metastatic and have high rate of recurrence due to the lack of effective systemic therapy. The identification of important survival pathways in uveal melanomas provides novel therapeutic targets for effective treatment. In the present study, we found that the NF-κB signaling pathway was constitutively and highly activated in uveal melanoma cells. Treatment with the pharmacological NF-κB specific inhibitor BAY11-7082 markedly decreased the nuclear translocation of NF-κB. In a dose-dependent setting, BAY11-7082 inhibited the proliferation and growth of uveal melanoma cells by inducing apoptosis without effect on cell cycle. The migration capacity of uveal melanoma cells was also significantly suppressed by BAY11-7082 treatment. Mechanistically, BAY11-7082 increased the activity of caspase 3 and reduced the expression of anti-apoptotic protein Bcl-2, but did not influence the expression of pro-apoptotic protein Bax. Furthermore, BAY11-7082 induced uveal melanoma cell apoptosis and inhibited xenograft tumor growth in vivo. Collectively, the present study identified NF-κB as an important survival signal for uveal melanoma cells and suggested that administration of specific NF-κB inhibitor BAY11-7082 could serve as an effective treatment for patients with uveal melanoma.

Original languageEnglish (US)
Pages (from-to)15653-15667
Number of pages15
JournalInternational Journal of Molecular Sciences
Volume13
Issue number12
DOIs
StatePublished - Jan 1 2012

Fingerprint

apoptosis
Cell death
inhibitors
Pharmacology
Apoptosis
Proteins
cells
Tumors
Apoptosis Regulatory Proteins
Cells
proteins
Therapeutics
therapy
Heterografts
Caspase 3
tumors
Survival
3-(4-methylphenylsulfonyl)-2-propenenitrile
Uveal melanoma
Growth

Keywords

  • Apoptosis
  • BAY11-7082
  • Cell migration
  • NF-κB
  • Uveal melanoma

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Medicine(all)

Cite this

The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells. / Hu, Shuiqing; Luo, Qingqiong; Cun, Biyun; Hu, Dan; Ge, Shengfang; Fan, Xianqun; Chen, Fuxiang.

In: International Journal of Molecular Sciences, Vol. 13, No. 12, 01.01.2012, p. 15653-15667.

Research output: Contribution to journalArticle

Hu, Shuiqing ; Luo, Qingqiong ; Cun, Biyun ; Hu, Dan ; Ge, Shengfang ; Fan, Xianqun ; Chen, Fuxiang. / The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells. In: International Journal of Molecular Sciences. 2012 ; Vol. 13, No. 12. pp. 15653-15667.
@article{1bda235bdf1e4ef8b9b89e5e8d9e436e,
title = "The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells",
abstract = "Uveal melanomas are highly metastatic and have high rate of recurrence due to the lack of effective systemic therapy. The identification of important survival pathways in uveal melanomas provides novel therapeutic targets for effective treatment. In the present study, we found that the NF-κB signaling pathway was constitutively and highly activated in uveal melanoma cells. Treatment with the pharmacological NF-κB specific inhibitor BAY11-7082 markedly decreased the nuclear translocation of NF-κB. In a dose-dependent setting, BAY11-7082 inhibited the proliferation and growth of uveal melanoma cells by inducing apoptosis without effect on cell cycle. The migration capacity of uveal melanoma cells was also significantly suppressed by BAY11-7082 treatment. Mechanistically, BAY11-7082 increased the activity of caspase 3 and reduced the expression of anti-apoptotic protein Bcl-2, but did not influence the expression of pro-apoptotic protein Bax. Furthermore, BAY11-7082 induced uveal melanoma cell apoptosis and inhibited xenograft tumor growth in vivo. Collectively, the present study identified NF-κB as an important survival signal for uveal melanoma cells and suggested that administration of specific NF-κB inhibitor BAY11-7082 could serve as an effective treatment for patients with uveal melanoma.",
keywords = "Apoptosis, BAY11-7082, Cell migration, NF-κB, Uveal melanoma",
author = "Shuiqing Hu and Qingqiong Luo and Biyun Cun and Dan Hu and Shengfang Ge and Xianqun Fan and Fuxiang Chen",
year = "2012",
month = "1",
day = "1",
doi = "10.3390/ijms131215653",
language = "English (US)",
volume = "13",
pages = "15653--15667",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells

AU - Hu, Shuiqing

AU - Luo, Qingqiong

AU - Cun, Biyun

AU - Hu, Dan

AU - Ge, Shengfang

AU - Fan, Xianqun

AU - Chen, Fuxiang

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Uveal melanomas are highly metastatic and have high rate of recurrence due to the lack of effective systemic therapy. The identification of important survival pathways in uveal melanomas provides novel therapeutic targets for effective treatment. In the present study, we found that the NF-κB signaling pathway was constitutively and highly activated in uveal melanoma cells. Treatment with the pharmacological NF-κB specific inhibitor BAY11-7082 markedly decreased the nuclear translocation of NF-κB. In a dose-dependent setting, BAY11-7082 inhibited the proliferation and growth of uveal melanoma cells by inducing apoptosis without effect on cell cycle. The migration capacity of uveal melanoma cells was also significantly suppressed by BAY11-7082 treatment. Mechanistically, BAY11-7082 increased the activity of caspase 3 and reduced the expression of anti-apoptotic protein Bcl-2, but did not influence the expression of pro-apoptotic protein Bax. Furthermore, BAY11-7082 induced uveal melanoma cell apoptosis and inhibited xenograft tumor growth in vivo. Collectively, the present study identified NF-κB as an important survival signal for uveal melanoma cells and suggested that administration of specific NF-κB inhibitor BAY11-7082 could serve as an effective treatment for patients with uveal melanoma.

AB - Uveal melanomas are highly metastatic and have high rate of recurrence due to the lack of effective systemic therapy. The identification of important survival pathways in uveal melanomas provides novel therapeutic targets for effective treatment. In the present study, we found that the NF-κB signaling pathway was constitutively and highly activated in uveal melanoma cells. Treatment with the pharmacological NF-κB specific inhibitor BAY11-7082 markedly decreased the nuclear translocation of NF-κB. In a dose-dependent setting, BAY11-7082 inhibited the proliferation and growth of uveal melanoma cells by inducing apoptosis without effect on cell cycle. The migration capacity of uveal melanoma cells was also significantly suppressed by BAY11-7082 treatment. Mechanistically, BAY11-7082 increased the activity of caspase 3 and reduced the expression of anti-apoptotic protein Bcl-2, but did not influence the expression of pro-apoptotic protein Bax. Furthermore, BAY11-7082 induced uveal melanoma cell apoptosis and inhibited xenograft tumor growth in vivo. Collectively, the present study identified NF-κB as an important survival signal for uveal melanoma cells and suggested that administration of specific NF-κB inhibitor BAY11-7082 could serve as an effective treatment for patients with uveal melanoma.

KW - Apoptosis

KW - BAY11-7082

KW - Cell migration

KW - NF-κB

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=84871676255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871676255&partnerID=8YFLogxK

U2 - 10.3390/ijms131215653

DO - 10.3390/ijms131215653

M3 - Article

VL - 13

SP - 15653

EP - 15667

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

ER -